Pancreatic Cancer Research

ResearcherMax Perutz LabsActive in the last 2 years

Dea Slade

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-0052-5910; OpenAlex author ID A5036704290. Sources: OpenAlex.

Their work

Papers
4 (first author 0, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
5
Papers, trials and grants by year

2024: 1 paper · 2025: none · 2026: 3 papers

Papers 4

  1. PARP7 inhibitors enhance the immunogenic effects of radiation in pancreatic cancer cells. Last author DOI 10.1016/j.omton.2026.201258↗
  2. ATR inhibition sensitizes pancreatic cancer cells to cytotoxic and immunogenic effects of X-ray and carbon ion irradiation. Last author DOI 10.1016/j.radonc.2026.111699↗
  3. Clonogenic survival and relative biological effectiveness of pancreatic ductal adenocarcinoma under pristine and spread-out Bragg peak irradiation with protons… Co-author DOI 10.64898/2026.09.30.754978↗
  4. Cytosolic nucleic acid sensors and interferon beta-1 activation drive radiation-induced anti-tumour immune effects in human pancreatic cancer cells. Last author DOI 10.3389/fimmu.2024.1286942↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Sylvia Gruber · 4 shared papers, 2024–2026 · strength 0.93
  2. Ana Beatriz Dias · 4 shared papers, 2024–2026 · strength 0.93
  3. Niccolo Bragato · 2 shared papers, 2026 · strength 0.50
  4. Chris J Beltran · 1 shared paper, 2026 · strength 0.26
  5. Janet M. Denbeigh · 1 shared paper, 2026 · strength 0.26

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.